AmacaThera Named Life Sciences Ontario Emerging Company of the Year

Recognition of AmacaThera's leadership and landmark agreement with Pacira BioSciences for its long?acting, opioid?sparing anesthetic in post?operative pain managementProgressing AMT-143 to Phase 2 clinical development in 2026View original content:https://www.prnewswire.co.uk/news-releases/amacathera-named-life-sciences-ontario-emerging-company-of-the-year-302684232.html

en | boerse | 68738393 |